Umbilical Cord-derived Mesenchymal Stem Cells Cultured in the MCL Medium for Aplastic Anemia Therapy

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2023 Aug 30

PMID 37649079

Authors

Chuan He

Chao Yang

Qiang Zeng

Zhigang Liu

Fangfang Wang

Qiang Chen

Ting Liu

Affiliations

Soon will be listed here.

Abstract

Background: Mesenchymal stem cells (MSCs) are a class of adult stem cells with self-renewal and multidirectional differentiation potential that may be a treatment for aplastic anemia (AA).

Method: Umbilical cord-derived MSCs were cultured in three media (Mesencult-XF, MCL, and StemPro MSC SFM CTS). HGF, PGE2, ANG-1, TGF-β1, IFN-γ, and TNF-α were detected using ELISA. The AA mouse model was built via post-irradiation lymphocyte infusion. After different treatments, routine blood, VEGF, and Tregs were detected every week. On day 28, all mice were killed, and their femurs were stained with HE.

Results: Umbilical cord-derived MSCs cultured in the three media all conformed to the general characteristics of MSCs. HGF secreted by MSCs in the Mesencult-XF, and MCL was greater than that in the StemPro MSC SFM CTS; ANG-1 and TGF-β1 in the MCL were more than that in Mesencult-XF and StemPro MSC SFM CTS; PGE2 in the MCL and StemPro MSC SFM CTS was more than that in the Mesencult-XF. MSCs in the MCL and StemPro MSC SFM CTS inhibited IFN-γ and TNF-α more than those in the Mesencult-XF. The peripheral blood cell in the AA groups was at a low level while that in the MSC group recovered rapidly. The Treg ratio and VEGF level in the MSC group were higher than those in the AA group. The bone marrow (BM) recovered significantly after MSC infusion.

Conclusion: MSCs in the MCL were advantageous in supporting hematopoiesis and modulating immunity and had the potential for effective treatment of AA.

Citing Articles

Mesenchymal stromal/stem cells from perinatal sources: biological facts, molecular biomarkers, and therapeutic promises.

Allouh M, Rizvi S, Alamri A, Jimoh Y, Aouda S, Ouda Z Stem Cell Res Ther. 2025; 16(1):127.

PMID: 40055783 PMC: 11889844. DOI: 10.1186/s13287-025-04254-0.

References

Huang Y, Huang S, Cai Y . [Effect of bone marrow mesenchymal stem cell infusion on hemato-poiesis in mice with aplastic anemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007; 15(5):1005-8. View

Costantino C, Baecher-Allan C, Hafler D . Human regulatory T cells and autoimmunity. Eur J Immunol. 2008; 38(4):921-4. PMC: 2752283. DOI: 10.1002/eji.200738104. View

Sarugaser R, Lickorish D, Baksh D, Hosseini M, Davies J . Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005; 23(2):220-9. DOI: 10.1634/stemcells.2004-0166. View

Swamynathan P, Venugopal P, Kannan S, Thej C, Kolkundar U, Bhagwat S . Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study. Stem Cell Res Ther. 2014; 5(4):88. PMC: 4247668. DOI: 10.1186/scrt477. View

Chamberlain G, Fox J, Ashton B, Middleton J . Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007; 25(11):2739-49. DOI: 10.1634/stemcells.2007-0197. View

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View

Ankrum J, Ong J, Karp J . Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014; 32(3):252-60. PMC: 4320647. DOI: 10.1038/nbt.2816. View

Sotiropoulou P, Perez S, Salagianni M, Baxevanis C, Papamichail M . Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2005; 24(2):462-71. DOI: 10.1634/stemcells.2004-0331. View

Borgstrom P, Hillan K, Sriramarao P, Ferrara N . Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 1996; 56(17):4032-9. View

10.

Watson N, Divers R, Kedar R, Mehindru A, Mehindru A, Borlongan M . Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells. Cytotherapy. 2014; 17(1):18-24. PMC: 4274214. DOI: 10.1016/j.jcyt.2014.08.009. View

11.

Troyer D, Weiss M . Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells. 2007; 26(3):591-9. PMC: 3311226. DOI: 10.1634/stemcells.2007-0439. View

12.

Nauta A, Fibbe W . Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007; 110(10):3499-506. DOI: 10.1182/blood-2007-02-069716. View

13.

Chatzistamatiou T, Papassavas A, Michalopoulos E, Gamaloutsos C, Mallis P, Gontika I . Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank. Transfusion. 2014; 54(12):3108-20. DOI: 10.1111/trf.12743. View

14.

Yang C, Chen Y, Li F, You M, Zhong L, Li W . The biological changes of umbilical cord mesenchymal stem cells in inflammatory environment induced by different cytokines. Mol Cell Biochem. 2018; 446(1-2):171-184. DOI: 10.1007/s11010-018-3284-1. View

15.

Campagnoli C, Roberts I, Kumar S, Bennett P, Bellantuono I, Fisk N . Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001; 98(8):2396-402. DOI: 10.1182/blood.v98.8.2396. View

16.

Nimer S, Leung D, Wolin M, Golde D . Serum stem cell factor levels in patients with aplastic anemia. Int J Hematol. 1994; 60(3):185-9. View

17.

Yang S, Lu S, Fei X, Zhang J, Shen W, Li J . [Change of cytokine expressions on bone marrow mesenchymal stem cells in patients with bone marrow failure syndromes and its significance]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010; 18(6):1560-3. View

18.

Huo J, Zhang L, Ren X, Li C, Li X, Dong P . Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia. Stem Cell Res Ther. 2020; 11(1):59. PMC: 7020384. DOI: 10.1186/s13287-020-1577-2. View

19.

Schugar R, Chirieleison S, Wescoe K, Schmidt B, Askew Y, Nance J . High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol. 2009; 2009:789526. PMC: 2796378. DOI: 10.1155/2009/789526. View

20.

Chao Y, Peng C, Harn H, Chan C, Wu K . Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia. Ann Hematol. 2010; 89(7):715-23. DOI: 10.1007/s00277-009-0892-6. View